Logo image of GP

GREENPOWER MOTOR CO INC (GP) Stock Fundamental Analysis

NASDAQ:GP - Nasdaq - CA39540E3023 - Common Stock - Currency: USD

0.438  +0.01 (+1.62%)

Fundamental Rating

1

GP gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 128 industry peers in the Machinery industry. GP has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, GP is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year GP has reported negative net income.
GP had a negative operating cash flow in the past year.
In the past 5 years GP always reported negative net income.
GP had a negative operating cash flow in each of the past 5 years.
GP Yearly Net Income VS EBIT VS OCF VS FCFGP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

GP has a worse Return On Assets (-57.43%) than 90.63% of its industry peers.
GP's Return On Equity of -1003.70% is on the low side compared to the rest of the industry. GP is outperformed by 91.41% of its industry peers.
Industry RankSector Rank
ROA -57.43%
ROE -1003.7%
ROIC N/A
ROA(3y)-31.51%
ROA(5y)-30.65%
ROE(3y)-85.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GP Yearly ROA, ROE, ROICGP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K 4K 5K

1.3 Margins

With a Gross Margin value of 8.32%, GP is not doing good in the industry: 89.84% of the companies in the same industry are doing better.
GP's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for GP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.3%
GM growth 5Y-14.89%
GP Yearly Profit, Operating, Gross MarginsGP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K -20K -25K

0

2. Health

2.1 Basic Checks

GP does not have a ROIC to compare to the WACC, probably because it is not profitable.
GP has more shares outstanding than it did 1 year ago.
The number of shares outstanding for GP has been increased compared to 5 years ago.
Compared to 1 year ago, GP has a worse debt to assets ratio.
GP Yearly Shares OutstandingGP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
GP Yearly Total Debt VS Total AssetsGP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Based on the Altman-Z score of -3.45, we must say that GP is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -3.45, GP is not doing good in the industry: 88.28% of the companies in the same industry are doing better.
A Debt/Equity ratio of 5.73 is on the high side and indicates that GP has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 5.73, GP is doing worse than 91.41% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.73
Debt/FCF N/A
Altman-Z -3.45
ROIC/WACCN/A
WACC8.52%
GP Yearly LT Debt VS Equity VS FCFGP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M 30M

2.3 Liquidity

A Current Ratio of 1.68 indicates that GP should not have too much problems paying its short term obligations.
GP has a Current ratio of 1.68. This is in the lower half of the industry: GP underperforms 67.19% of its industry peers.
GP has a Quick Ratio of 1.68. This is a bad value and indicates that GP is not financially healthy enough and could expect problems in meeting its short term obligations.
GP has a Quick ratio of 0.18. This is amonst the worse of the industry: GP underperforms 95.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.68
Quick Ratio 0.18
GP Yearly Current Assets VS Current LiabilitesGP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

5

3. Growth

3.1 Past

GP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.07%.
GP shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -58.29%.
GP shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.21% yearly.
EPS 1Y (TTM)-36.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-58.29%
Revenue growth 3Y43.51%
Revenue growth 5Y45.21%
Sales Q2Q%-11.51%

3.2 Future

Based on estimates for the next years, GP will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.60% on average per year.
The Revenue is expected to grow by 17.68% on average over the next years. This is quite good.
EPS Next Y-1.57%
EPS Next 2Y14.91%
EPS Next 3Y16.6%
EPS Next 5YN/A
Revenue Next Year-44.95%
Revenue Next 2Y3.41%
Revenue Next 3Y17.68%
Revenue Next 5YN/A

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
GP Yearly Revenue VS EstimatesGP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M
GP Yearly EPS VS EstimatesGP Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

0

4. Valuation

4.1 Price/Earnings Ratio

GP reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year GP is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GP Price Earnings VS Forward Price EarningsGP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GP Per share dataGP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5

4.3 Compensation for Growth

GP's earnings are expected to grow with 16.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.91%
EPS Next 3Y16.6%

0

5. Dividend

5.1 Amount

No dividends for GP!.
Industry RankSector Rank
Dividend Yield N/A

GREENPOWER MOTOR CO INC

NASDAQ:GP (4/17/2025, 8:25:19 PM)

0.438

+0.01 (+1.62%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)06-30 2025-06-30/bmo
Inst Owners2.02%
Inst Owner Change0.75%
Ins Owners22.37%
Ins Owner ChangeN/A
Market Cap12.92M
Analysts84.44
Price Target1.29 (194.52%)
Short Float %1.92%
Short Ratio2.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.44%
Min EPS beat(2)-0.03%
Max EPS beat(2)2.91%
EPS beat(4)2
Avg EPS beat(4)-11.54%
Min EPS beat(4)-54.2%
Max EPS beat(4)5.17%
EPS beat(8)2
Avg EPS beat(8)-17.29%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)8.78%
Min Revenue beat(2)-6.47%
Max Revenue beat(2)24.04%
Revenue beat(4)1
Avg Revenue beat(4)-12.85%
Min Revenue beat(4)-40.62%
Max Revenue beat(4)24.04%
Revenue beat(8)2
Avg Revenue beat(8)-15.72%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.62%
PT rev (3m)4.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.67%
EPS NY rev (1m)-2.16%
EPS NY rev (3m)-12.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.58%
Revenue NY rev (1m)0%
Revenue NY rev (3m)4.39%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 6.04
P/tB 6.04
EV/EBITDA N/A
EPS(TTM)-0.83
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.36
OCFYN/A
SpS0.7
BVpS0.07
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -57.43%
ROE -1003.7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.32%
FCFM N/A
ROA(3y)-31.51%
ROA(5y)-30.65%
ROE(3y)-85.54%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-20.3%
GM growth 5Y-14.89%
F-Score1
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 5.73
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 8.42%
Cap/Sales 0.73%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.68
Quick Ratio 0.18
Altman-Z -3.45
F-Score1
WACC8.52%
ROIC/WACCN/A
Cap/Depr(3y)43.22%
Cap/Depr(5y)47.66%
Cap/Sales(3y)1.64%
Cap/Sales(5y)1.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-1.57%
EPS Next 2Y14.91%
EPS Next 3Y16.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-58.29%
Revenue growth 3Y43.51%
Revenue growth 5Y45.21%
Sales Q2Q%-11.51%
Revenue Next Year-44.95%
Revenue Next 2Y3.41%
Revenue Next 3Y17.68%
Revenue Next 5YN/A
EBIT growth 1Y-40.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.06%
EBIT Next 3Y18.64%
EBIT Next 5YN/A
FCF growth 1Y1.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1.63%
OCF growth 3YN/A
OCF growth 5YN/A